BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers

NCT01550380 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: BKM120

Sponsor

University of Utah

Collaborators

[object Object]